VioVet Blog - Veterinary Matters

Search the blog:

  • Introducing Yurvac RHD Image

    Yurvac RHD is a vaccine containing recombinant rabbit haemorrhagic disease virus (RHDV2). It is indicated for the active immunisation of rabbits from 30 days of age onwards against RHDV and RHDV2. The product has only just received a positive opinion for initial marketing with the EMA on the 11th to 13th July so it will be a while before it is rele...

    Read More
  • Introducing Eluracat Image

    Eluracat contains the active ingredient capromorelin tartrate. It is a new medicinal product intended for use in cats for body weight gain. It is particularly indicated for those experiencing unintended weight loss or reduced appetite resulting from chronic medical conditions. The product has only just received a positive opinion for initial market...

    Read More
  • Introducing Prolevare Image

    Introducing Prolevare

    27 February 2023 (Last Updated: 27 February 2023) - by in Veterinary Matters

    Prolevare contains oclacitinib maleate, a JAK inhibitor. It is indicated for the treatment of pruritus associated with allergic dermatitis in dogs and the treatment of clinical manifestations of atopic dermatitis in dogs. The product has only just received a positive opinion for initial marketing with the EMA on the 21st February 2023 so it will be...

    Read More
  • Introducing Eurican L4 Image

    Introducing Eurican L4

    27 February 2023 (Last Updated: 27 February 2023) - by in Veterinary Matters

    Eurican L4 is a vaccination for injection in dogs. It induces an immune response against 4 strains of Leptospirosis: - Leptospira interrogans serogroup Canicola serovar Canicola, - Leptospira interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagiae, - Leptospira kirschneri serogroup Grippotyphosa serovar Grippotyphosa, and - Leptospira...

    Read More
  • Introducing Neoleish Image

    Introducing Neoleish

    15 December 2022 - by in Veterinary Matters

    Neoleish is a vaccination which consists of plasmid DNA containing the LACK gene from Leishmania infantum. It is intended for use in stimulating a protective immune response against Leishmaniasis in dogs from 6 months of age. The onset of this immunity is 58 days and the duration 6 months after the primary vaccination course. The vaccination does n...

    Read More
  • Introducing Mometamax Ultra Image

    Introducing Mometamax Ultra

    17 October 2022 (Last Updated: 5 March 2024) - by in Veterinary Matters

    Mometamax Ultra is a topical ear treatment product containing the antibiotic ‘gentamicin’, the antifungal ‘posaconazole’ and the steroid ‘mometasone furoate’. It is indicated for the treatment of Otitis Externa or recurrent Otitis. The product has only just received a positive opinion for initial marketing on the...

    Read More
  • Introducing Lotilaner Elanco Image

    Introducing Lotilaner Elanco

    15 July 2022 (Last Updated: 29 February 2024) - by in Veterinary Matters

    Lotilaner Elanco contains the active ingredient lotilaner which is an antiparasitic medication from the isoxazoline class. It works by inhibiting gamma–aminobutyric acid (GABA)-gated chloride channels, and so killing target parasites. It is licensed for use in dogs and cats and comes in the form of a chewable tablet. The product has only just...

    Read More
  • Introducing RenuTend Image

    RenuTend contains tenogennic primed equine allogeneic peripheral blood-derived mesenchymal stem cells. It comes as a suspension for injection for use in horses. The intended use is to promote tissue healing mechanisms in ligaments and tendons, in particular improving the healing of tendon and suspensory ligament injuries. The product has only just...

    Read More
  • Introducing Chanaxin Image

    Chanaxin contains Tulathromycin, an antibiotic from the Macrolides class. It will come as a solution for injection and is intended for use in cattle, pigs and sheep. It is indicated for the following treatments: Cattle Metaphylaxis of Bovine Respiratory Disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni...

    Read More
  • Introducing Imoxat Image

    Introducing Imoxat

    14 October 2021 (Last Updated: 11 December 2023) - by in Veterinary Matters

    Imoxat is an anti-parasitic veterinary medication for cats, dogs and ferrets containing imidacloprid and moxidectin These ingredients are effective against fleas, mites and roundworm including lungworm and heartworm. The product comes in a spot on form and is a great option for preventing infestations of these parasites in target animals. The produ...

    Read More